CG Oncology Inc. (CGON) vs Iovance Biotherapeutics, Inc. (IOVA)
A side-by-side comparison of CG Oncology Inc. and Iovance Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$65.47HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
IOVA
Iovance Biotherapeutics, Inc.
$13.28HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CGON vs IOVA
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)IOVA +85.2% (+22.8%/yr)IOVA compounded faster over this window
CGON IOVA
CGON vs IOVA: by the numbers
- •IOVA is the larger company ($5.93B vs $5.77B market cap).
- •Both run net losses; IOVA's is the smaller (-89.09% vs -3602.68% net margin).
Metrics side by side
Valuation
| Metric | CGON | IOVA |
|---|---|---|
| P/S ratio | 927.13 | 18.24 |
| P/B ratio | 5.61 | 8.05 |
Profitability
| Metric | CGON | IOVA |
|---|---|---|
| Gross margin | -15.02% | 97.23% |
| Operating margin | -4722.13% | -153.08% |
| Net margin | -3602.68% | -89.09% |
| ROE | -21.80% | -39.33% |
| ROIC | -24.33% | -37.26% |
Growth (annualized)
| Metric | CGON | IOVA |
|---|---|---|
| Total return CAGR (5Y) | N/A | -11.55% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.